Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US medical thefts developing into national trend, say authorities:

This article was originally published in Clinica

Executive Summary

The recent theft of several million dollars' worth of high-value medical equipment in the Pittsburgh region is part of a national trend, says the FBI, which has received a seemingly regular flow of reports of endoscope thefts dating back to 2004. The University of North Carolina Hospitals have speculated that individuals are taking the equipment to start up in private practice or are selling the goods on. There appears to be a thriving internet-based black market in second-hand endoscopes, which are being bought up by overseas - sometimes third-world - countries. Concern over the emerging trend has prompted the International Association for Healthcare Security and Safety (Glendale Heights, Illinois) to plan a survey of its members and ascertain the extent of the problem.

You may also be interested in...



QUOTED. 20 February 2020. Steven Raman.

Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.

Novartis Logs Into India With Digital Innovation Hub

Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.

Rx List Price Inflation Penalty Endorsed By US HHS Secretary

Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.

Topics

UsernamePublicRestriction

Register

MT047999

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel